TALENOM Commercial Services & Supplies/Finland, February 9, 2018 Spot comment
|
|
- Caitlin Copeland
- 5 years ago
- Views:
Transcription
1 Price/EUR Strong growth to continue Rating BUY Talenom s Q4 results were in line with our expectations except for a one-off write-off on software, which affected EBIT. The guidance for 2018 implies stronger growth than previously anticipated and we have made changes to our near-term estimates. We retain our BUY-recommendation with a target price of EUR 13.4 (13.2). Write-offs affected Q4 results Talenom s Q4 EBIT was EUR 0.9m against our estimates of EUR 1.3m. EBIT was affected by a one-off write-off on older software having an effect of EUR 0.4m. Sales in Q4 were EUR 10.7m against our estimates of EUR 10.5m. Guiding strong growth and slight profitability improvement Talenom expects revenue growth in 2018 to be clearly faster than in 2017 (12.1 %). We have revised our 2018 and 2019 sales growth estimates upward by 4 %p and 1 %p respectively. The sales from additional services (excluding advisory) in 2017 were EUR 0.45m, but as a larger part of the sales accrued towards the end of the year we expect major increases during Due to the in absolute figures still small volumes, we estimate the effect on Talenom s sales growth to only be around two percentage points. We further expect the acquisitions made in early 2018 to have an additional effect on sales of some EUR 1.5-2m. We also expect sales growth in bookkeeping services to remain strong, as Talenom s franchising-chain has seen good growth during 2017 and new customers will contribute to sales with some delay. Talenom expects the EBIT-margin to improve slightly from We have only made minor adjustments to our 2018 estimates and expect an EBIT-margin of 13.4 %. BUY with a target price of EUR 13.4 (13.2) We have revised our target price to EUR 13.4 (13.2) to reflect our changed estimates. The guidance leaves slight room for sales growth upside but with the low visibility into the additional services we remain conservative to sales development. KEY FIGURES /15 06/16 06/17 Talenom DJ STOXX 600 Share price, EUR (Last trading day s closing price) Target price, EUR 13.4 Latest change in recommendation 09-Feb-18 Latest report on company 09-Feb-18 Research paid by issuer: YES No. of shares outstanding, 000 s 6,859 No. of shares fully diluted, 000 s 6,859 Market cap, EURm 83 Free float, % 55.7 Exchange rate Reuters code TNOM.HE Bloomberg code TNOM FH Average daily volume, EURm Next interim report 26-Apr-18 Web site Analyst Jerker Salokivi jerker.salokivi@evli.com Telephone BUY HOLD SELL Sales EBIT EBIT Ptx profit EPS P/E EV/Sales P/CF EV/EBIT DPS EURm EURm % EURm EUR (x) (x) (x) (x) EUR % % E % E % E % Market cap, EURm 83 BV per share 2018E, EUR 2.4 CAGR EPS , % 17.0 Net debt 2018E, EURm 19 Price/book 2018E 5.1 CAGR sales , % 12.6 Enterprise value, EURm 102 Dividend yield 2018E, % 3.2 ROE 2018E, % 30.3 Total assets 2018E, EURm 50 Tax rate 2018E, % 20.0 ROCE 2018E, % 16.7 Goodwill 2018E, EURm 18 Equity ratio 2018E, % 32.7 PEG, P/E 18/CAGR 1.4 All the important disclosures can be found on the last pages of this report. 1(10)
2 VALUATION RESULTS BASE CASE DETAILS VALUATION ASSUMPTIONS ASSUMPTIONS FOR WACC Current share price PV of Free Cash Flow 31 Long-term growth, % 2.3 Risk-free interest rate, % 2.25 DCF share value PV of Horizon value 84 WACC, % 7.4 Market risk premium, % 5.8 Share price potential, % 18.4 Unconsolidated equity 0 Spread, % 0.5 Debt risk premium, % 3.3 Maximum value 16.4 Marketable securities 5 Minimum WACC, % 6.9 Equity beta coefficient 0.80 Minimum value 12.5 Debt - dividend -22 Maximum WACC, % 7.9 Target debt ratio, % 25 Horizon value, % 72.9 Value of stock 98 Nr of shares, Mn 6.9 Effective tax rate, % 20 DCF valuation, EURm E 2019E 2020E 2021E 2022E 2023E 2024E 2025E 2026E 2027E Horizon Net sales Sales growth, % Operating income (EBIT) EBIT margin, % Depreciation+amort Income taxes Change in NWC NWC / Sales, % Change in other liabs Capital Expenditure Investments / Sales, % Other items = Unlevered Free CF (FCF) = Discounted FCF (DFCF) = DFCF min WACC = DFCF max WACC (10)
3 INTERIM FIGURES EVLI ESTIMATES, EURm 2017Q1 2017Q2 2017Q3 2017Q Q1E 2018Q2E 2018Q3E 2018Q4E 2018E 2019E 2020E Net sales EBITDA EBITDA margin (%) EBIT EBIT margin (%) Net financial items Pre-tax profit Tax Tax rate (%) Net profit EPS EPS adjusted (diluted no. of shares) Dividend per share SALES, EURm Talenom Total SALES GROWTH, Y/Y % Talenom Total EBIT, EURm Talenom Total EBIT margin, % Talenom Total (10)
4 INCOME STATEMENT, EURm E 2019E 2020E Sales Sales growth (%) Costs Reported EBITDA Extraordinary items in EBITDA EBITDA margin (%) Depreciation EBITA Goodwill amortization / writedown Reported EBIT EBIT margin (%) Net financials Pre-tax profit Extraordinary items Taxes Minority shares Net profit BALANCE SHEET, EURm Assets Fixed assets % of sales Goodwill % of sales Inventory % of sales Receivables % of sales Liquid funds % of sales Total assets Liabilities Equity % of sales Deferred taxes % of sales Interest bearing debt % of sales Non-interest bearing current liabilities % of sales Other interest free debt % of sales Total liabilities CASH FLOW, EURm + EBITDA Net financial items Taxes Increase in Net Working Capital /- Other = Cash flow from operations Capex Acquisitions Divestments = Net cash flow /- Change in interest-bearing debt /- New issues/buybacks Paid dividend /- Change in loan receivables Change in cash (10)
5 KEY FIGURES E 2019E 2020E M-cap Net debt Enterprise value Sales EBITDA EBIT Pre-tax Earnings Book value Valuation multiples EV/sales EV/EBITDA EV/EBITA EV/EBIT EV/operating cash flow EV/cash earnings P/E P/E excl. goodwill P/B P/sales P/CF Target EV/EBIT Target P/E Target P/B Per share measures 101 6,084 6,807 6,812 6,859 6,859 6,859 (diluted) 101 6,084 6,807 6,812 6,859 6,859 6,859 EPS EPS excl. goodwill Cash EPS Operating cash flow per share Capital employed per share Book value per share Book value excl. goodwill Dividend per share Dividend payout ratio, % Dividend yield, % Efficiency measures ROE ROCE Financial ratios Capex/sales, % Capex/depreciation excl. goodwill,% Net debt/ebitda, book-weighted Debt/equity, market-weighted Equity ratio, book-weighted Gearing Number of employees, average Sales per employee, EUR 60,856 56,116 68,186 67,571 72,635 78,154 81,915 EBIT per employee, EUR 3,176 2,075 7,707 7,896 9,714 10,785 11,468 5(10)
6 COMPANY DESCRIPTION: Talenom Oyj operates as an accounting company. The Company offers accounting, bookkeeping, taxation, and legal services, as well as invoicing, financial performance monitoring and management software, and payroll services. INVESTMENT CASE: OWNERSHIP STRUCTURE SHARES EURm % Tahkola Harri 1,564, % Ilmarinen Mutual Pension Insurance Company 1,181, % Tahkola Markus 1,059, % Danske Capital Finland (through its funds) 474, % Finnish Industry Investment 344, % Hulkko Juha 170, % EQ Asset Management 160, % Siuruainen Mikko 155, % Varma Mutual Pension Insurance Company 145, % Dividend House 88, % Ten largest 5,342, % Residual 1,516, % Total 6,859, % EARNINGS CALENDAR April 26, 2018 August 02, 2018 October 25, 2018 Q1 report Q2 report Q3 report OTHER EVENTS March 14, 2018 AGM COMPANY MISCELLANEOUS CEO: Jussi Paaso CFO: Antti Aho IR: Töölönlahdenkatu 3B, Helsinki Tel: 6(10)
7 DEFINITIONS P/E Price per share Earnings per share EPS Profitbeforeextraordinary items andtaxes income taxes minority interest P/Sales Marketcap Sales DPS Dividend for the financial period per share P/BV Priceper share Shareholders' equity taxedprovisionsper share CEPS Gross cash flowfromoperations P/CF Priceper share Operatingcash flowper share EV/Share Enterprise value EV (Enterprise value) Marketcap net debt minority interest atmarket value share of associated companiesatmarket value Sales/Share Sales Net debt Interest bearingdebt financialassets EBITDA/Share Earningsbeforeinterest, tax, depreciationandamortisation EV/Sales Enterprise value Sales EBIT/Share Operatingprofit EV/EBITDA Earnings before Enterprise value interest, tax, depreciation and amortisation EAFI/Share Pretax profit EV/EBIT Enterprise value Operating profit Capital employed/share Totalassets non interest bearingdebt Div yield, % Dividend per share Priceper share Total assets Balance sheet total Payout ratio, % Totaldividends Earningsbeforeextraordinary items andtaxes income taxes minority interest Interest coverage (x) Operatingprofit Financialitems Net cash/share Financial assets interest bearing debt Asset turnover (x) Turnover Balancesheet total(average) ROA, % Operatingprofit Balancesheet total financial income extraordinary items interest free short termdebt longtermadvancesreceived andaccountspayable(average) ROCE, % Profitbeforeextraordinary items interest expenses other financialcosts Balancesheet total noninterest bearing debt (average) ROE, % Profit before extraordinary items and taxes income taxes Shareholders' equity minority interest taxedprovisions (average) Debt/Equity, % Interest bearing debt Shareholders' equity minority interest taxed provisions Equity ratio, % Shareholders' equity minority interest taxedprovisions Totalassets interest freeloans CAGR, % Cumulative annualgrowthrate Averagegrowthper year 7(10)
8 Important Disclosures Evli Research Partners Plc ( ERP ) uses 12-month target prices. Target prices are defined by utilizing analytical techniques based on financial theory including (but not limited to) discounted cash flow analysis and comparative valuation. The selection of valuation methods depends on different circumstances. Target prices may be altered on the basis of new information coming to light in the underlying company or changes in interest rates, changes in foreign exchange rates, other securities prices or market indices or outlook for the aforementioned factors or other factors that may change the conditions of financial markets. Recommendations and changes by analysts are available at Detailed information about the valuation or methodology and the underlying assumptions is accessible via ERP: Investment recommendations are defined as follows: Target price compared to share price Recommendation < -10 % SELL -10 (+10) % HOLD > 10 % BUY ERP s investment recommendation of the analyzed company is in general updated 2 4 per year. The graph above shows the distribution of ERP s recommendations of companies under coverage in 22nd of February If recommendation is not given, it is not mentioned here. Name(s) of the analyst(s): Salokivi This research report has been prepared by Evli Research Partners Plc ( ERP or Evli Research ). ERP is a subsidiary of Evli Bank Plc. Production of the investment recommendation has been concluded on [ , 8:30]. This report has been published on [ , 8:45]. None of the analysts contributing to this report, persons under their guardianship or corporations under their control have a position in the shares of the company or related securities. The date and time for any price of financial instruments mentioned in the recommendation refer to the previous trading day s closing price(s) unless otherwise stated in the report. Each analyst responsible for the content of this report assures that the expressed views accurately reflect the personal views of each analyst on the covered companies and securities. Each analyst assures that (s)he has not been, nor are or will be, receiving direct or indirect compensation related to the specific recommendations or views contained in this report. Companies in the Evli Group, affiliates or staff of companies in the Evli Group, may perform services for, solicit business from, hold long or short positions in, or otherwise be interested in the investments (including derivatives) of any company mentioned in the publication or report. Neither ERP nor any company within the Evli Group have managed or co-managed a public offering of the company s securities during the last 12 months prior to, received compensation for investment banking services from the company during the last 12 months prior to the publication of the research report. ERP may pursue an assignment from the issuer(s) of the financial instruments mentioned in the recommendation or this report. These assignments may have a limited economic or financial impact on ERP and/or Evli. Under such assignments ERP may perform services including, but not limited to, arranging investor meetings or events, investor relations communication advisory and production of research material. ERP has signed an agreement with the issuer of the financial instruments mentioned in the recommendation, which includes production of research reports. This assignment has a limited economic and financial impact on ERP and/or Evli. Under the assignment ERP performs services including, but not limited to, arranging investor meetings or events, investor relations communication advisory and production of research material. ERP or another company within the Evli Group does not have an agreement with the company to perform market making services. For the prevention and avoidance of conflicts of interests with respect to this report, there is an information barrier (Chinese wall) between Investment Research and Corporate Finance units concerning unpublished investment banking services to the company. The remuneration of the analyst(s) is not tied directly or indirectly to investment banking transactions performed by Evli Bank Plc or any company within Evli Group. This report has not been disclosed to the company prior to its dissemination. 8(10)
9 This report is provided and intended for informational purposes only and may not be used or considered under any circumstances as an offer to sell or buy any securities or as advice to trade any securities. This report is based on sources ERP considers to be correct and reliable. The sources include information providers Reuters and Bloomberg, stock-exchange releases from the companies and other company news, Statistics Finland and articles in newspapers and magazines. However, ERP does not guarantee the materialization, correctness, accuracy or completeness of the information, opinions, estimates or forecasts expressed or implied in the report. In addition, circumstantial changes may have an influence on opinions and estimates presented in this report. The opinions and estimates presented are valid at the moment of their publication and they can be changed without a separate announcement. Neither ERP nor any company within the Evli Group are responsible for amending, correcting or updating any information, opinions or estimates contained in this report. Neither ERP nor any company within the Evli Group will compensate any direct or consequential loss caused by or derived from the use of the information represented in this publication. All information published in this report is for the original recipient s private and internal use only. ERP reserves all rights to the report. No part of this publication may be reproduced or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, or stored in any retrieval system of any nature, without the written permission of ERP. This report or its copy may not be published or distributed in Australia, Canada, Hong Kong, Japan, New Zealand, Singapore or South Africa. The publication or distribution of this report in certain other jurisdictions may also be restricted by law. Persons into whose possession this report comes are required to inform themselves about and to observe any such restrictions. Evli Bank Plc is not registered as a broker-dealer with the U. S. Securities and Exchange Commission ( SEC ), and it and its analysts are not subject to SEC rules on securities analysts certification as to the currency of their views reflected in the research report. Evli Bank is not a member of the Financial Industry Regulatory Authority ( FINRA ). It and its securities analysts are not subject to FINRA s rules on Communications with the Public and Research Analysts and Research Reports and the attendant requirements for fairness, balance and disclosure of potential conflicts of interest. This research report is only being offered in U.S. by Auerbach Grayson & Company, LLC (Auerbach Grayson) to Major U.S. Institutional Investors and is not available to, and should not be used by, any U.S. person or entity that is not a Major U.S. Institutional Investor. Auerbach Grayson is a broker-dealer registered with the U.S. Securities and Exchange Commission and is a member of the FINRA. U.S. entities seeking more information about any of the issuers or securities discussed in this report should contact Auerbach Grayson. The securities of non-u.s. issuers may not be registered with or subject to SEC reporting and other requirements. ERP is not a supervised entity but its parent company Evli Bank Plc is supervised by the Finnish Financial Supervision Authority. 9(10)
10 Contact information SALES AND TRADING HELSINKI Equity Sales Trading ETFs and Derivatives Ari Laine Lauri Vehkaluoto (Head) Tobias Björk (Head) Lauri Ahokanto Pasi Väisänen Joachim Dannberg Niclas Henelius Antti Kässi Kimmo Lilja Structured Investments Corporate Bonds sales and trading Derivatives Trading Heikki Savijoki Jukka Hyvönen Sami Järvinen Aki Lakkisto Thomas Kaukonen Evli Investment Solutions Johannes Asuja Markku Reinikainen SALES AND TRADING STOCKHOLM Urban Lawesson (Head) Thomas Kåhrström EQUITY RESEARCH Forestry, Pulp&Paper, Chemicals, Utilities, Packaging Retail, Consumer Goods, Telecommunications, Healthcare Research Analysts Markku Järvinen (Head of Research, Finland) Joonas Häyhä Olli Pöyhönen Jerker Salokivi Technology, Software Construction, Real Estate Jonas Forslund Tomi Lindell EVLI BANK PLC Aleksanterinkatu 19 A P.O. Box 1081 FIN Helsinki, FINLAND Phone Fax Internet firstname.lastname@evli.com EVLI BANK PLC, STOCKHOLMSFILIAL Kungsgatan 27, P.O. Box SE Stockholm Sverige stockholm@evli.com Tel +46 (0) Fax +46 (0) (10)
NEXT GAMES Software/Finland, November 6, 2017 Spot comment
Price/EUR Growth slow down Rating HOLD Next Games third quarter was below our expectations and although the growth phase does not warrant focus on single quarters the results do imply some faster than
More informationOLVI Food, Beverage & Tobacco/Finland, November 6, 2018 Spot comment
Price/EUR Upgraded to Buy Olvi continued strong delivery in Q3 and could be positioned to upgrade guidance again later in 2018E, in our view. We think valuation now looks too stretched considering strong
More informationNOKIA Communications Equipment/Finland, November 22, 2018 Company report
Price/EUR Re-initiating coverage with BUY and TP 5.50 euros Given the acceleration of 5G, coupled with Nokia s strategy and execution capabilities, we see Nokia able to deliver both net sales growth and
More informationSTORAENSO Paper & Forest Products/Finland, October 26, 2015 Spot comment
Downgrade to ACCUMULATE Rating ACCUMULATE Stora Enso s Q3 was supported by pulp and FX. Seasonally weaker Q4 is guided to be in line with Q3, backed by EUR 40m less maintenance. Varkaus kraftliner conversion
More informationELISA Telecommunication services/finland, October 28, 2014 Company update
Now attractively valued After Elisa s Q3 report and Capital Markets Day takeaways, we upgrade our recommendation to Accumulate ( Reduce ). The current share price appears too low, given the strong margins
More informationINNOFACTOR Software/Finland, June 2, 2017 Company report
Target: Leader in all Nordic countries Rating BUY We initiate coverage of Innofactor with BUY recommendation and target price of EUR 1.85. Innofactor s acquisition driven growth phase is shifting towards
More informationMATELAN Research. InVision 49.0 Buy. Excellent margin trend in Prelims. Update Note. 24 February Company / Sector Fair Value Recommendation
Update Note Price as of 21/02/13: 4 24 February 2014 Company / Sector Fair Value Recommendation InVision 49.0 Buy Technology: Cloud Computing ( 34) (Buy) Excellent margin trend in Prelims Share price performance
More information2014 E 2015 E 2016 E 2017 E
Equity Research 4 December 2014 Interpump Group Hydraulics M&A may power growth Rating BUY Target price EUR13 Interpump is up 25% since the beginning of the year, bolstered by strong interim results and
More informationAdvanced Vision Techn Buy
16/9/13 16/11/13 16/1/14 16/3/14 16/5/14 16/7/14 16/9/14 16/11/14 16/1/15 16/3/15 16/5/15 16/7/15 MATELAN Research Update Note Closing price as of 13/8/15: 9.16 14 August 215 Company / Sector Fair Value
More informationBDI BioEnergy Internat Buy
13/08/12 13/10/12 13/12/12 13/02/13 13/04/13 13/06/13 13/08/13 13/10/13 13/12/13 13/02/14 13/04/14 13/06/14 13/08/14 MATELAN Research Update Note Price as of 13/08/14: 10.29 14 August 2014 Company / Sector
More informationAlmarai Steady performance
RSI10 ALMARAI AB: Saudi Arabia Rating Target price Current price NEUTRAL SAR55.05 (-4.59% upside) SAR57.66 Key themes & implications Almarai reported a positive top-line in Q1 2016, showing resilience
More informationISRA VISION Neutral
Update Note Closing price as of 1/8/17: 142.8 4 September 217 Company / Sector Fair Value Recommendation ISRA VISION 128. Neutral Technology: Machine Vision ( 128.) (unchanged) Solid Q3 leaves company
More informationContextVision. Solid 2Q and more details on the contract awaited. August 18 th 2014 Share price: NOK Target: NOK Risk: Medium.
August 18 th 2014 Share price: NOK 21.70 Target: NOK 24.00 Risk: Medium ContextVision Key share data Sector Reuters Bloomberg Health Care COVI.OL COV:NO Market Cap (NOKm) 167.9 Net debt (NOKm) -28.6 EV
More informationE 2015E 2016E
IAR Systems Group AB Q3 Another strong report Analyst: Johan Broström +46 70 428 31 74 Date: 24 October 2014 Continuing strong demand and currency effects, now positively impacting sales and earnings,
More informationContextVision. Neutral stance maintained after 3Q. 3Q14 Results analysis November 5 th 2014 Share price: NOK Target: NOK 24.
3Q14 Results analysis November 5 th 2014 Share price: NOK 22.00 Target: NOK 24.00 Risk: Medium ContextVision Key share data Sector Reuters Bloomberg ContextVision is a market making client of Norne Securities
More informationContextVision. Expecting solid results and awaiting progress update on research program
1Q17 Preview (report due April 27 th ) April 24 th 2017 Share price: NOK 61.75 Target: NOK 100.00 (unchanged) Risk: Medium ContextVision Key share data Sector Reuters Bloomberg Health Care COVI.OL COV
More informationYansab Better than expected results
YANSAB AB: Saudi Arabia US$6.91bn 39.8% US$23.37mn Market cap Free float Avg. daily volume RSI10 Vol th Target price n/a n/a Consensus price 56.00 21.5% over current Current price 46.10 as at 9/2/2011
More informationPetro Rabigh Shutdown marred Q2 results
PETROR AB: Saudi Arabia US$5.07bn 17.4% US$11.19mn Market cap Free float Avg. daily volume RSI10 Vol th Target price n/a n/a Consensus price 32.18 48.3% over current Current price 21.70 as at 17/8/2011
More informationTrevi Group Italy Capital goods
30 August 2013 Trevi Group Italy Capital goods Buy (Hold) Target price EUR6.90 Current price EUR6.22 Matteo Bonizzoni, CFA mbonizzoni@keplercheuvreux.com +39 02 80 62 83 43 Sound delivery and business
More informationVery solid Q3; excellent story, but priced in; TP upped to 60.00; downgrade to neutral. Q3 2016: Very solid quarter, better than expected
B a sl er A G # $T ypcap$ 1576 14 1 1 x 6495 2 Page 1/6 First Take Reco. lowered Neutral vs Buy Electronics Germany Neutral Target price : 60.00 EUR vs 52.00 EUR Price (11/01/2016) : 58.04 EUR Upside :
More informationZain KSA bogged down by high debt
Vol th RSI10 Zain KSA ZAINKSA AB: Saudi Arabia US$2.464bn 48.3% US$16.50mn Market cap Free float Avg. daily volume Target price 7.30 12.31% over current Consensus price 7.62 17.2% over current Current
More informationStrong growth ahead QUIRIN PRIVATBANK EQUITY RESEARCH. 18 Mai 2017 EQS Group AG
18 Mai 2017 EQS Group AG Rating Buy (Buy) Share price (EUR) 52.50 Target price (EUR) 60.00 (50.00) Bloomberg Sector EQS GY Technology Share data Shares out (m) 1.3 Daily volume shs (m) 0.0 Free float (%)
More informationNovo Nordisk. Equity Research. Teaching FDA a lesson. (Unchanged) Key financials. Flash note 29 November 2016
Equity Research Investment Research Novo Nordisk Flash note 29 November 2016 Buy (Unchanged) Teaching FDA a lesson In 2013, the FDA delayed the approval of Novo s Tresiba due to a vague signal showing
More information1 January 31 March 2018
TALENOM PLC. BUSINESS REVIEW JANUARY MARCH 2018 (UNAUDITED): STRONG GROWTH CONTINUED, PROFITABILITY ROSE SIGNIFICANTLY - NET SALES UP BY 18.1%, EBIT UP BY 42.4% 1 January 31 March 2018 Talenom is an accounting
More informationZain KSA restructuring ensures fresh start
Vol mn RSI10 Zain KSA ZAINKSA AB: Saudi Arabia US$5.41bn 48.3% US$142.1mn Market cap Free float Avg. daily volume Target price 15.90 9.68% over current Consensus price 16.10 11.0% over current Current
More informationSABIC Overall strong performance
SABIC AB: Saudi Arabia US$80.80bn 22.6% US$124.7mn Market cap Free float Avg. daily volume RSI10 Vol th Target price 126.0 24.75% over current Consensus price 125.6 24.4% over current Current price 101.0
More informationENDOMINES Metals & Mining/Sweden, March 22, 2018 Company report
Price/SEK Initiate coverage with BUY Rating BUY Through a recent transaction Endomines acquired American entity TVL Gold and the five gold assets it holds. With the completed rights issue and financing
More informationE 2015E
IAR Systems Group AB Q2 Upside earnings surprise Analyst: Johan Broström +46 70 428 31 74 Date: 22 August 2014 Margins for IAR Systems were an upside surprise in Q2, pushing operating profit to SEK 12.7
More informationWe do not take a stance on the dispute
We do not take a stance on the dispute We have continued to clarify the dispute between Afarak s owners. We have concluded that we cannot reliably evaluate the matter s potential juridical consequences
More informationINDRA SPAIN \ TECHNOLOGY
INDRA SPAIN \ TECHNOLOGY Company Update NR (prev. Buy) Target: 14.5 (prev. 17) Risk: High STOCK DATA Price 13.97 Bloomberg Code IDR SM Market Cap. ( mn) 2,269 Free Float 59.31% Shares Out. (mn) 162 52-week
More informationHAEMATO AG SOLID UPTICK IN H2 SALES AND EBIT MARGIN. FIRST BERLIN Equity Research PRICE TARGET H A
FIRST BERLIN Equity Research HAEMATO AG RATING Germany / Pharma 2017 Frankfurt PRICE TARGET 7.40 Bloomberg: HAE GR Prelims Return Potential 25.4% ISIN: DE0006190705 Risk Rating High SOLID UPTICK IN H2
More informationExamples = + = + = = = =
Examples = + = + = = = = Calculation of ratios an example Formula Year 1 Year 2 Year 3 Year 4 Year 5 Comments Adjusted Profit/Loss for the Period excl. Minorities 33.0 37.4 36.8 62.3 79.4 Adjusted
More informationTHE NAVIGATOR COMPANY. 2 nd Quarter earnings support production and price rises. Navigator's key ratios. Source: Company s data, BiG Research
Ticker: NVG PL Recommendation: BUY Share details (EUR) Current price 5.01 Target price Upside 6.39 27.5 Beta 1.0 52w max 6.055 52w low 3.469 1y return () 43.39 3m return () 9.12 Market cap (mn) 3,595 Free
More informationMETOXOI TITANAS (TITK) 7 Νοεμβρίου 2017
OVERVIEW 07/11/2017 Sector Construction & Materials Industry Buildings, Materials, Fixtures Mrk Cap 1.565.169.840 Employees 5.482 Last Trade 20.31 Price Range (52 week) Average Volume 19,820 26,750 Shares
More informationRajesh Exports (RJEX_IN) Earnings Update Report Consumer Discretionary: Gold Jewelry Manufacturer
Monday, February 4, 2019 www.evaluateresearch.com Target Price Rs. 900.00 Current Price Rs. 598.00 Upside Potential 50% Market Cap. Shares Outstanding Rs. 176,802 mn US$ 2.47 bn 295.3 mn Free Float (FF
More informationItway (ITW.IM) 1H 08/09 results: once again affected by the crisis June 16, 2009
Itway (.IM) Sector: IT / Distribution HOLD 1H 08/09 results: once again affected by the crisis June 16, 2009 Investment view Itway is active in the marketing and licensing of technologies for e-business
More informationChina Renewable Energy Investment Ltd (987_HK)
Wednesday, March 21, 2018 www.evaluateresearch.com Target Price HK$ 0.50 Current Price HK$ 0.23 Upside Potential 117% Market Cap. Shares Outstanding HK$ 525 mn $ 66.90 mn 2,364.7 mn Free Float (FF %) 631.9
More informationHCL Technologies. Rating: Target price: EPS: Target CMP. Rating. Rs. 826 REDUCE. Rs.760
: price: EPS: How does our one year outlook change? HCLT registered a strong quarter with revenues growing at 6.5% qoq (4% qoq organic) including $40m contribution from Volvo, after a disappointing show
More informationResults Review. 3QFY13: Downsizing its workforce. Technology Bloomberg Ticker: UNI MK Bursa Code: November 2013
Results Review (Member of Alliance Bank group) PP7766/03/2013 (032116) 8 November 2013 Analyst Toh Woo Kim wookim@alliancefg.com +603 2604 3917 12-month upside potential Previous target price 0.89 Revised
More informationRajesh Exports Bloomberg: RJEX_IN Consumer Discretionary: Gold Jewellery Manufacturer
Monday, February 15, 2016 www.evaluateresearch.com Target Price Rs. 915.00 Current Price Rs. 720.00 Upside Potential 25% Market Cap. Shares Outstanding Rs. 214,048mn $ 3.15bn 295mn Free Float (FF %) 77mn
More informationTOFAS. Company Update. Still offers potential value BUY. Rating. 19 February 2019
Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Company Update TOFAS Still offers potential value Tofas has been a laggard in the last one-year period, due to weaker
More informationSipchem Petrochemicals Industrial SIPCHEM AB: Saudi Arabia 07 August 2014
RSI10 Sipchem SIPCHEM AB: Saudi Arabia Rating Target price Current price NEUTRAL SAR40.98 (7.6% upside) SAR38.10 Sector rating Company risk rating Key themes & implications Outperform Low Sipchem recently
More informationKalpataru Power. Rating: Target price: EPS: Rating CMP. Target BUY. Rs Rs.256
: price: EPS: How does our one year outlook change? We expect KPP s revenue (standalone) to grow by 21% y-o-y in FY17E backed by an order book of Rs. 91bn (1.7x FY17E book-to-bill). Both Transmission line
More informationOpus Group. Equity Research. US could be supportive. Buy (Neutral) Target price: SEK 9.00 (10.0) Share price: SEK August, 2015.
Equity Research 21 August, 20 Opus Group US could be supportive Q2 EBITDA slightly better than expected US platform in place Relative pricing in favor Q2 figures The Q2 EBITDA of SEK 94m (88) was 2-3%
More informationSIILI SOLUTIONS IT Services 12 March H2/2012 Small cap update
SIILI SOLUTIONS IT Services 12 March 213 - H2/212 Small cap update NO RATING PRICE Siili Solutions 8.5 Closing price as of 11.3.213 High/Low 12m 8.5 / 7. COMPANY DATA Mcap 13.3 EV 1.3 No. of shares (out)
More informationLUCISANO MEDIA GROUP. New partner for Lucisano. Buy (maintained) Company Update
LUCISANO MEDIA GROUP Company Update Buy (maintained) 5:30PM MARKET PRICE: EUR2.82 TARGET PRICE: EUR3.40 (unchanged) Entertainment Data Shares Outstanding (m): 14.88 Market Cap. (EURm): 41.96 Enterprise
More informationDynamics change but net debt continues to rise
EQUITIES IT SERVICES INDRA UNDERPERFORM EUR12.2 TARGET PRICE EUR9 (DOWNSIDE 26%) TARGET PRICE EPS 13e EPS 14e unchanged -16% -14% Dynamics change but net debt continues to rise 1 NOVEMBER 2013 Brice Prunas
More informationTrevi Finanziaria. Debt worries seem excessive. 19 February 2009 Capital Goods Change in Estimates. Price: 5.07 Target price: 6.
19 February 2009 Capital Goods Change in Estimates Price: 5.07 Target price: 6.90 Outperform 18 16 14 12 19/2/09 EPS Adj. ( ) 0.83 1.06 1.06 1.24 DPS ( ) 0.10 0.10 0.10 0.13 BVPS ( ) 2.23 3.19 4.14 5.28
More informationMa aden Equity infusion will strengthen balance sheet
RSI10 Ma aden MAADEN AB: Saudi Arabia Rating Target price Current price OVERWEIGHT SAR42.0 (19.4% upside) SAR35.17 Research Department ARC Research Team Tel 966 11 211 9332, gopij@alrajhi-capital.com Key
More informationHighlight & Recent Developments MYTILINEOS SIGNS AN AGREEMENT FOR A NEW POWER PLANT IN LIBYA
Sector OVERVIEW 18/08/ Basic Materials Industry EPC, Metallurgy, Energy, Gas trading Mrk Cap 1.284.591.537 Employees 2.009 Last Trade 8.53 Price Range (52 week) Average Volume 5.018 8.77 Shares Outstanding
More information7C Solarparken GUIDANCE FOR 2016 INCREASED. FIRST BERLIN Equity Research. Preliminary 2014 PRICE TARGET 2.10
FIRST BERLIN Equity Research 12 7C Solarparken AG 7 RATING Germany / Cleantech Preliminary 2014 Primary Exchange: Frankfurt PRICE TARGET 2.10 Bloomberg: HRPK GF figures Return Potential 13.9% ISIN: DE000A11QW68
More information1 November 2017 M1 Kliniken AG. FIRST BERLIN Equity Research. Update following
FIRST BERLIN Equity Research M1 Kliniken AG RATING Germany / Healthcare Facilities & Services Update following Frankfurt PRICE TARGET 16.50 Bloomberg: M12 GR capital increase Return Potential 44.7% ISIN:
More informationINNOFACTOR. Danish country manager suspected misconduct led to assessment error in financials. IT Services 21 October Result Comment NO RATING
INNOFACTOR IT Services 21 October 2015 - Result Comment NO RATING PRICE Innofactor 0,78 Price as of 19.10.2015 High/Low 12m 1,17 / 0,76 COMPANY DATA Mcap 26 EV 36 No. of shares (out) 33,5 No. of shares
More informationCardinal Health, Inc. - Financial and Strategic SWOT Analysis Review
Publication Date: FEB 2013 7000 Cardinal Place Phone Revenue Dublin, OH Fax Net Profit 43017 Website Employees United States Exchange Industry Company Overview Cardinal Health, Inc. (Cardinal Health) is
More informationTrevi Finanziaria. New investments to meet material intake. 12 May 2008 Capital Goods Update. Price: Target price: 16.
12 May 2008 Capital Goods Update Price: 16.44 Target price: 16.80 Outperform 17 16 15 14 13 12/5/08 2006 2007 2008E 2009E EPS Adj. ( ) 0.42 0.83 0.99 1.28 DPS ( ) 0.05 0.10 0.13 0.16 BVPS ( ) 1.91 2.23
More informationVontobel Morning Note
Vontobel Morning Note 05-09-12 Contact your sales desk: Zurich : +41 58 283 50 51 London: +44 207 255 83 00 Cologne: +49 221 20 30 00 New York: +1 212 792 58 20 Summary What's new? - RICHEMONT (Buy, 70.0):
More informationSaudi Ceramic Expansion plan key growth driver
RSI10 Construction and Materials Industrial SCERCO AB: Saudi Arabia Rating NEUTRAL Target price SAR116. 0 (4.5% upside) Current SAR111.3 price Key themes & implications Company is one of the leading ceramic
More informationPA Power Automation AG
February 08, 2017 Information Analysis Analysts: Daniel Großjohann, Dr. Roger Becker, CEFA +49 69 71 91 838-42, -46 daniel.grossjohann@bankm.de, roger.becker@bankm.de Evaluation result Fair value HOLD
More informationEBIT-positive in Q3. FY guidance revised down
EQUITIES INFRASTRUCTURE TREVI FINANZIARIA INDUSTRIALE NEUTRAL EUR1.10 TARGET PRICE EUR1.20 (UPSIDE 9%) TARGET PRICE EPS 15e EPS 16e -8% NM -2% EBIT-positive in Q3. FY guidance revised down 17 NOVEMBER
More informationMCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176
: price: EPS: Tepid volume growth continues 4QFY15 traded volumes in MCX showed a small improvement sequentially whereas declined yoy. FY15 traded Values are at a sever year low. We retain our cautious
More informationEXPERT SYSTEM. Weak results in. Buy. Company Update. 14 October :30 PM. IT Services
EXPERT SYSTEM Company Update 5:30 PM MARKET PRICE: EUR2.02 Buy TARGET PRICE: EUR2.32 (from EUR2.55) IT Services Data Shares Outstanding (m): 27.7 Market Cap. (EURm): 55.8 Enterprise Value (EURm): 69.8
More informationFineotex Chemical Ltd
Company Update Decent Performance under Macroeconomic Pressure; Business Traction to Continue: Fineotex Chemical recorded decent set of result as consolidated sales grew by 1.1% YoY (largely in line) to
More informationUnilever Nigeria Plc. Cost control remains a challenge. Nigeria Equities Consumer Goods July 24, 2015
Unilever Nigeria Plc Nigeria Equities Consumer Goods July 24, 2015 Cost control remains a challenge 1H2015 revenue declines by 1.9% y/y For the six months period to June 2015, Unilever Nigeria recorded
More informationEXPERT SYSTEM. Weaker than expected 2016 results and challenging business plan. Hold (from Buy) Company Update
EXPERT SYSTEM Company Update Hold (from Buy) 5:30PM MARKET PRICE: EUR1.81 TARGET PRICE: EUR1.89 (from EUR2.32) Entertainment Data Shares Outstanding (m): 27.7 Market Cap. (EURm): 50.5 Enterprise Value
More informationHOLD (previous: BUY) (previous: 68.00)
February 23, 2017 Information Analysis Analyst Daniel Großjohann +49 69 71 91 838-42 daniel.grossjohann@bankm.de Evaluation Result Fair Value HOLD 69.00 (previous: BUY) (previous: 68.00) BankM Research
More informationSiili Solutions. Capital Markets Day 14 November Capital Markets Day and new financial targets ; 9:00, 1
14.11.2018; 9:00, 1 13/11/17 13/01/18 13/03/18 13/05/18 13/07/18 13/09/18 SHARE Company Price 8,38 Price as of 13.11.2018 High/Low 12m 12,5 / 7,6 COMPANY DATA Market Cap. Current 59 EV current 55 No. of
More informationZAIN KSA. Promising turnaround story OVERWEIGHT UPSIDE +16.3%
TELECOM OVERWEIGHT UPSIDE +16.3 CURRENT PRICE SAR9.8 TARGET PRICE SAR11.4 RATING CHANGE Promising turnaround story We upgrade Zain to overweight with a TP of SAR11.4. We believe Zain s turnaround story
More informationVisaka Industries Ltd
Company Update Superior Product Mix & New Age Markets to Aid Growth New investments to aid growth: Visaka continues to give a good set of numbers. YoY EPS grew at 142% aided by a revenue growth of 1.5%
More informationSaudi Arabian Mining Co (Maaden AB Equity) Continuing steady performance
Vol mn RSI10 Saudi Arabian Mining Co- Mining Industrial MAADEN AB: Saudi Arabia 29 May 2018 US$17.47bn 35% US$6.79mn Market cap Free float Avg. daily volume Target price 47.60-15.5% over current Current
More informationBOMI ITALIA. Buoyant results in 1H17 and acquisition of minorities. Buy (maintained) Company Update. 20 September :30 PM.
Company Update Buy (maintained) 5:30 PM MARKET PRICE: EUR2.70 TARGET PRICE: EUR4.14 (from EUR3.46) Home Automation Data Shares Outstanding (m): 15.23 Market Cap. (EURm): 41.05 Enterprise Value (EURm):
More informationKPN Telecom Operators - Netherlands
Exane BNP Paribas Equity Research Preview KPN Telecom Operators - Netherlands Stock vs Sector Neutral Sector vs Market Neutral Price (30 January 2007) EUR11.2 Target price 10.5 (-6%) Earnings revisions
More informationBorussia Dortmund GmbH & Co. KGaA
A cc or # 6 $T ypcap$ 1628 1 0 4 2 Page 1/7 Equity flash Trading Update Entertainment BUY (BUY) Target EUR 5.00 (EUR 5.00) Price (last closing price) : EUR 3.91 Upside : 28% Est. change 2015e 2016e EPS
More information13 May 2016 PNE WIND AG. FIRST BERLIN Equity Research
FIRST BERLIN Equity Research PNE WIND AG RATING Germany / Cleantech Primary exchange: Frankfurt Q1/16 figures PRICE TARGET 3.30 Bloomberg: PNE3 GR Return Potential 50.1% ISIN: DE000A0JBPG2 Risk Rating
More informationIndra. Hold July 2009 LAST PRICE CHANGE IN RECOMMENDATION
20 July 2009 Indra LAST PRICE Hold 15.95 CHANGE IN RECOMMENDATION Bloomberg IDR SM Reuters IDR.MC Share price Target price 15.95 17.05 Market Cap N. Shares 2.68bn 164.1m Main Shareholders CajaMadrid 19.8%
More informationTrevi Finanziaria. Growth driven by Middle East and US. 12 October 2007 Industrials Change in Estimates. Price: Target price: 16.
12 October 2007 Industrials Change in Estimates Price: 14.53 Target price: 16.40 Outperform 15 14 13 12 12/10/07 2005 2006 EPS Adj. ( ) 0.20 0.42 0.66 0.87 1.05 DPS ( ) 0.03 0.05 0.08 0.11 0.14 BVPS (
More informationNational Industrialization Co. Diversified Operations Industrial NIC AB: Saudi Arabia 25 May 2014
RSI10 National Industrialization Co. NIC AB: Saudi Arabia 25 May 2014 Rating Target price Current price OVERWEIGHT SAR37.30 (18.7% upside) SAR31.40 Key themes & implications Sluggish petrochemical prices
More informationEQUINET INVESTIGATOR
Hypoport 2 January 211 Financials Bloomberg: HYQ GR Market Cap: EUR 72m Free Float: 35% Current Share Price: EUR 11.8 Buy / Target EUR 17 Profile Hypoport is an internet-based financial services provider
More informationSiili Solutions. Result Comment 28 February International sales growth very strong , 1
28.2.2018, 1 27/02/17 27/04/17 27/06/17 27/08/17 27/10/17 27/12/17 27/02/18 SHARE Company Price 12,30 Price as of 28.2.2018 High/Low 12m 13,48 / 9,1 COMPANY DATA Market Cap. Current 86 EV current 75 No.
More informationBuy (Buy) Equity story yet to unfold. keplercheuvreux.com. Equity Research Espresso SANT
EQCR Germa ny Target GR 5.60 Equity Research Espresso SANT price change F Full report S&T Buy (Buy) Germany IT software & services MCAP EUR 240.3m Target Price EUR 6.70 23 December 2015 Current Price Up/downside
More informationKey estimate revision. Financial summary. Year FY15 121, % 16, % FY16E 137, % 20,
: price: EPS: How does our one year outlook change? We maintain rating on Aurobindo post the company s 3QFY16 results. Revenue growth for the quarter was 10% yoy: US sales of $238mn (vs. estimate of $251mn
More informationSINTERCAST. Installation revenue increased Positive market outlook No major changes SHARE PRICE (SEK): 84,50 INTRODUCE.SE
216-12-2 SHARE PRICE (SEK): SINTERCAST 84,5 NASDAQ OMX Small Cap Industrials Installation revenue increased Positive market outlook No major changes Installation revenue increased. Sintercast presented
More informationSAFARICOM LTD EARNINGS UPDATE MAY 2016
SAFARICOM LTD EARNINGS UPDATE MAY 2016 A I B C A P I T A L L T D We maintain our target estimates and only adjust for time value of money and debt on the valuation. We also factor in current numbers and
More informationTrevi Finanziaria. First half confirms growth trend. 20 September 2006 Industrials Change in Estimates. Price: 6.65 Target price: 7.
20 September 2006 Industrials Change in Estimates Price: 6.65 Target price: 7.70 Outperform 8.00 7.50 7.00 6.50 6.00 18/9/06 2004 2005 2006E 2007E EPS Adj. ( ) 0.04 0.20 0.38 0.48 DPS ( ) 0.02 0.07 0.12
More informationSolid preliminary FY 2014 results released. Net asset value increased by 3.5% in H 2014 with difficult trading environment
A cc or # $T ypcap$ 1628 1 0 4 2 Equity flash Trading Update Financial Services Scherzer & Co. AG BUY (BUY) Target 1.80 EUR (1.80 EUR) Price (last closing price) : 1.56 EUR Upside : 15% Est.. change 2015e
More informationSimmtech (222800) Focus on 2H earnings WHAT S THE STORY?
Company Update Simmtech (222800) Focus on 2H earnings Simmtech yesterday reported disappointing 4Q results, which compels us to cut our 2018 operating profit forecast by 10% to KRW52.9b and 12-month target
More informationHOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance
RAMCO S HOLD Target Price: Rs 503 Deleveraging story playing out Ramco Cements total debt reduced by a massive Rs 5 bn to Rs 22 bn in FY16. The company generated total EBITDA of Rs 11.5 bn in FY16 and
More informationAdani Ports & SEZ Rating: Target price: EPS:
Adani Ports & SEZ : price: EPS: Volume traction continues in a seasonally good quarter; maintain Adani Ports & SEZ reported a good quarter with total operating revenues (standalone) of Rs. 8.02bn and PAT
More informationSFC Energy AG STRONG GROWTH AND PROFITABILITY AHEAD. FIRST BERLIN Equity Research. Preliminary PRICE TARGET S F
FIRST BERLIN Equity Research SFC Energy AG RATING Germany / Energy Preliminary Primary exchange: Frankfurt PRICE TARGET 8.70 Bloomberg: F3C GR 2017 figures Return Potential 13.3% ISIN: DE0007568578 Risk
More informationHCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.
Jan-14 Mar-14 Apr-14 May-14 Jul-14 Aug-14 Sep-14 Nov-14 Dec-14 Jan-15 India Research Infrastructure April 10, 2015 EVENT UPDATE Bloomberg: IN Reuters: HCNS.BO BUY QIP step in the right direction has successfully
More informationHold Dec 2018 TP (IDR) 49,450 Consensus Price (IDR) 52,798 TP to Consensus Price -6.3% vs. Last Price -8.3%
Unilever Indonesia Tbk (UNVR) Dilemma: Inclining Debt vs Declining Dividend 2017 Performance Review UNVR posted the increment of 2.9% in sales from IDR40 trillion in 2016 into IDR41.2 trillion in 2017.
More informationGillette India. Institutional Equities. 1QFY18 Result Update
1QFY18 Result Update Institutional Equities Gillette India 14 November 2017 Reuters: GILE.NS; Bloomberg: GILL IN Robust Growth In Operating Margin Gillette India s or GIL s overall top-line performance
More informationSINTERCAST. Record series production Higher installation activity in the autumn Stable platform SHARE PRICE (SEK): 83,25 INTRODUCE.
216-9-2 SHARE PRICE (SEK): SINTERCAST 83,25 NASDAQ OMX Small Cap Industrials Record series production Higher installation activity in the autumn Stable platform Record series production. In Q2 SinterCast
More information3,951 EBITDA 1,174 1,153 1,260 1,284 1,332 Outst shares (mn) 57 EBIT Free float (%)
European Equity Research ACCIONA Facing a Good 2017E Spain Electricity November 7, 2016 (07:15 CET) BUY CURRENT PRICE: 69.01 TARGET PRICE: 82.40 ANA released 9M16 results on Nov 4 and we have adjusted
More informationQuarterly results (YE Mar) 2QFY14 2QFY15 % yoy H1FY14 H1FY15 % yoy
India I Equities Healthcare Result Update 3 November 2014 Granules India Strong performance, margin improvement to sustain; Buy Rating: Buy Target Price: `1,185 Share Price: `807 Key takeaways Strong quarter.
More informationDeoleo has chosen CVC
EQUITIES FOOD & HPC DEOLEO UNDERPERFORM EUR0.43 TARGET PRICE EUR0.32 (DOWNSIDE 25%) Deoleo has chosen CVC 11 APRIL 2014 Francisco Ruiz (+34) 91 114 83 06 francisco.ruiz@exanebnpparibas.com spanish-midcaps@exanebnpparibas.com
More informationDubai Financial Market
June 21, 2009 Fair Value Estimate: AED 2.04 Recommendation:: Hold Executive Summary DFM posted a weak operating result in Q1 2009. Total revenue fell 24.7% q-o-q to AED 68.6mn due to lower trading commission
More informationKey estimate revision. Financial summary. Year
: price: EPS: How does our one year outlook change? We retain our positive outlook on WIL and believe that revival in MHCV industry, increasing content per vehicle and opportunity in exports would drive
More informationBUY (previous: BUY) (previous: 77.50)
November 10, 2017 Information Analysis Analyst: Daniel Grossjohann +49 69 71 91 838-42 Daniel.grossjohann@bankm.de Evaluation result Fair value BUY 75.65 (previous: BUY) (previous: 77.50) Find BankM Research
More informationDr Reddy s Laboratories
: price: EPS: How does our one year outlook change? We maintain rating on DRRD post the company s 3QFY16 results Revenue growth for the quarter was muted (3% yoy) due to disappointing performances in Russia
More informationJamna Auto Industries
2QFY19 Result Update Institutional Equities Jamna Auto Industries Reuters: JMNA.NS; Bloomberg: JMNA IN Performance Below Expectations; Retain Buy Due To Strong Outlook Jamna Auto s 2QFY19 earnings were
More information